Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. (ARTV) Insider Trading
Directors, officers and holders of more than 10% of ARTV report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 145 transactions on file: 7 with code P, 15 with code S and 28 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Horan Christopher | Chief Tech Operations Officer | S Sale | 10,423 | $4.18 | $43,580 |
| Nov 2, 2026 | Aslan Fred | Chief Executive Officer | S Sale | 62,178 | $4.18 | $259,972 |
| Nov 2, 2026 | Bush Jennifer | COO, CLO, Compliance Officer | S Sale | 8,439 | $4.18 | $35,284 |
| Nov 2, 2026 | Banerjee Subhashis | Chief Medical Officer | S Sale | 1,110 | $4.18 | $4,641 |
| Oct 6, 2026 | Aslan Fred | Chief Executive Officer | S Sale | 23,463 | $7.20 | $168,880 |
| Oct 5, 2026 | Banerjee Subhashis | Chief Medical Officer | S Sale | 1,099 | $6.84 | $7,514 |
| Oct 5, 2026 | Aslan Fred | Chief Executive Officer | S Sale | 61,696 | $6.84 | $421,828 |
| Oct 5, 2026 | Horan Christopher | Chief Tech Operations Officer | S Sale | 10,340 | $6.84 | $70,697 |
| Oct 5, 2026 | Bush Jennifer | COO, CLO, Compliance Officer | S Sale | 8,370 | $6.84 | $57,227 |
| Sep 15, 2026 | Aslan Fred | Chief Executive Officer | A Award | 315,000 | Not measured | Not measured |
| Sep 15, 2026 | Aslan Fred | Chief Executive Officer | A Award | 110,000 | Not measured | Not measured |
| Sep 10, 2026 | HOUGEN ELIZABETH L | Director | A Award | 16,250 | Not measured | Not measured |
| Sep 10, 2026 | DANIELS BRIAN | Director | A Award | 16,250 | Not measured | Not measured |
| Sep 10, 2026 | Aslan Fred | Chief Executive Officer | A Award | 45,000 | Not measured | Not measured |
| Sep 10, 2026 | Aslan Fred | Chief Executive Officer | A Award | 155,000 | Not measured | Not measured |
| Sep 10, 2026 | Sorg Elaine K. | Director | A Award | 16,250 | Not measured | Not measured |
| Sep 10, 2026 | Stoppel Laura | Director | A Award | 16,250 | Not measured | Not measured |
| Sep 10, 2026 | Baker Daniel G. | Director | A Award | 16,250 | Not measured | Not measured |
| Sep 10, 2026 | MOORE ALISON | Director | A Award | 16,250 | Not measured | Not measured |
| Sep 10, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | A Award | 16,250 | Not measured | Not measured |
| Sep 9, 2026 | Banerjee Subhashis | Chief Medical Officer | A Award | 30,000 | Not measured | Not measured |
| Sep 9, 2026 | Horan Christopher | Chief Tech Operations Officer | A Award | 40,000 | Not measured | Not measured |
| Sep 9, 2026 | Horan Christopher | Chief Tech Operations Officer | A Award | 120,000 | Not measured | Not measured |
| Sep 9, 2026 | Bush Jennifer | COO, CLO, Compliance Officer | A Award | 135,000 | Not measured | Not measured |
| Sep 9, 2026 | Bush Jennifer | COO, CLO, Compliance Officer | A Award | 45,000 | Not measured | Not measured |
| Sep 9, 2026 | Miralles Gines Diego | President & Head of R&D | A Award | 45,000 | Not measured | Not measured |
| Sep 9, 2026 | Banerjee Subhashis | Chief Medical Officer | A Award | 85,000 | Not measured | Not measured |
| Sep 9, 2026 | Miralles Gines Diego | President & Head of R&D | A Award | 135,000 | Not measured | Not measured |
| Sep 8, 2026 | DANIELS BRIAN | Director | A Award | 13,750 | Not measured | Not measured |
| Sep 8, 2026 | HOUGEN ELIZABETH L | Director | A Award | 13,750 | Not measured | Not measured |
| Sep 8, 2026 | Baker Daniel G. | Director | A Award | 13,750 | Not measured | Not measured |
| Sep 8, 2026 | Stoppel Laura | Director | A Award | 13,750 | Not measured | Not measured |
| Sep 8, 2026 | Aslan Fred | Chief Executive Officer | S Sale | 23,429 | $10.92 | $255,746 |
| Sep 8, 2026 | MOORE ALISON | Director | A Award | 13,750 | Not measured | Not measured |
| Sep 8, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | A Award | 13,750 | Not measured | Not measured |
| Sep 8, 2026 | Sorg Elaine K. | Director | A Award | 13,750 | Not measured | Not measured |
| Sep 3, 2026 | Banerjee Subhashis | Chief Medical Officer | S Sale | 1,100 | $11.16 | $12,271 |
| Sep 3, 2026 | Horan Christopher | Chief Tech Operations Officer | S Sale | 10,366 | $11.16 | $115,638 |
| Sep 3, 2026 | Aslan Fred | Chief Executive Officer | S Sale | 61,888 | $11.16 | $690,392 |
| Sep 3, 2026 | Bush Jennifer | COO, CLO, Compliance Officer | S Sale | 8,391 | $11.16 | $93,606 |
| Aug 18, 2026 | Banerjee Subhashis | Chief Medical Officer | S Sale | 429 | $12.00 | $5,148 |
| Aug 18, 2026 | Banerjee Subhashis | Chief Medical Officer | M Exercise | 429 | $1.92 | $824 |
| Aug 18, 2026 | Banerjee Subhashis | Chief Medical Officer | M Exercise | 429 | Not measured | Not measured |
| Jul 24, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | P Purchase | 41,319 | $9.99 | $412,777 |
| Jul 23, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | P Purchase | 59,880 | $9.96 | $596,405 |
| Jul 22, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | P Purchase | 84,124 | $9.93 | $835,351 |
| Jul 21, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | P Purchase | 120,582 | $9.55 | $1,151,558 |
| Jul 17, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | P Purchase | 7,882 | $8.95 | $70,544 |
| Jul 16, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | P Purchase | 152,472 | $8.93 | $1,361,575 |
| Jul 13, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | P Purchase | 6,552 | $8.94 | $58,575 |
The full Form 4 history is on the ARTV company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.